Compartir
array:23 [ "pii" => "S0025775321005303" "issn" => "00257753" "doi" => "10.1016/j.medcli.2021.07.022" "estado" => "S300" "fechaPublicacion" => "2022-05-13" "aid" => "5810" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:446-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S0025775321006047" "issn" => "00257753" "doi" => "10.1016/j.medcli.2021.09.015" "estado" => "S300" "fechaPublicacion" => "2022-05-13" "aid" => "5821" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:447-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Esplenectomía de urgencia tras rotura espontánea de bazo en paciente afectado de malaria" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "447" "paginaFinal" => "448" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Emergency splenectomy after spontaneous rupture in a patient with malaria" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José Luis García Galocha, Alejandra García Botella, Antonio Jose Torres García" "autores" => array:3 [ 0 => array:2 [ "nombre" => "José Luis" "apellidos" => "García Galocha" ] 1 => array:2 [ "nombre" => "Alejandra" "apellidos" => "García Botella" ] 2 => array:2 [ "nombre" => "Antonio Jose" "apellidos" => "Torres García" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020622001735" "doi" => "10.1016/j.medcle.2021.09.014" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622001735?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775321006047?idApp=UINPBA00004N" "url" => "/00257753/0000015800000009/v1_202205040537/S0025775321006047/v1_202205040537/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S002577532100511X" "issn" => "00257753" "doi" => "10.1016/j.medcli.2021.07.014" "estado" => "S300" "fechaPublicacion" => "2022-05-13" "aid" => "5791" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:445-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Panuveitis bilateral como complicación del tratamiento sistémico de melanoma" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "445" "paginaFinal" => "446" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Bilateral panuveitis as a complication of systemic treatment of melanoma" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Assumció López Paradís, Sofia España Fernández, Jose Luis Manzano Mozo" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Assumció" "apellidos" => "López Paradís" ] 1 => array:2 [ "nombre" => "Sofia" "apellidos" => "España Fernández" ] 2 => array:2 [ "nombre" => "Jose Luis" "apellidos" => "Manzano Mozo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020622001693" "doi" => "10.1016/j.medcle.2022.04.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622001693?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002577532100511X?idApp=UINPBA00004N" "url" => "/00257753/0000015800000009/v1_202205040537/S002577532100511X/v1_202205040537/es/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Honeycomb buccal mucosa lesions induced by checkpoint inhibitors" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "446" "paginaFinal" => "447" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Carlos Moreno-Vílchez, Octavio Servitje, Joaquim Marcoval" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Carlos" "apellidos" => "Moreno-Vílchez" "email" => array:1 [ 0 => "cmorenov@bellvitgehospital.cat" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Octavio" "apellidos" => "Servitje" ] 2 => array:2 [ "nombre" => "Joaquim" "apellidos" => "Marcoval" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Dermatology, Hospital Universitari de Bellvitge, Universitat de Barcelona, Carrer de la Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Lesiones en panel de abeja en mucosa yugal inducidas por inmunoterapia" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 598 "Ancho" => 900 "Tamanyo" => 77707 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Reticular streaks converging in a well-defined honeycomb pattern in buccal mucosa in a patient treated with pembrolizumab for metastatic cutaneous melanoma.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Lichenoid reactions have recently been described in patients treated with anti-PD-1 antibodies<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">1</span></a>; however, clinical and pathological features in these patients have been poorly reported in the literature and are based on isolated cases. We report 3 consecutive cases treated with checkpoint inhibitors for advanced solid tumors in whom muco-cutaneous lichenoid lesions developed. We emphasize in the clinical features of the oral manifestations.</p><p id="par0010" class="elsevierStylePara elsevierViewall">A 66-year-old man presented with a 1-month history of asymptomatic reticular streaks affecting the lip and buccal mucosa (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Physical examination also revealed multiple polygonal erythematous papules on the wrists. The patient had a history of metastatic cutaneous melanoma and was included two years ago in a phase III clinical trial with pembrolizumab–levatinib vs pembrolizumab alone. The mucocutaneous manifestations started between cycles 25 and 26 of treatment. The clinical findings were consistent with lichen planus-like drug eruption possibly secondary to anti-PD-1 treatment. The treatment with pembrolizumab was interrupted temporally and after one month in treatment with oral corticoids the lesions disappeared.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">A 74-year-old man, with metastatic clear cell renal carcinoma on treatment with nivolumab, presented with a 3-month history of erythematous polygonal papules with fine desquamation involving the wrists and upper legs. Asymptomatic reticular confluent lesions were present in lip and buccal mucosa. The lesions developed after his second cycle of nivolumab. A lichenoid reaction to nivolumab was suspected and a biopsy of a papular lesion of the wrist was performed, confirming the diagnosis. After two months with topical corticosteroids the improvement was remarkable.</p><p id="par0020" class="elsevierStylePara elsevierViewall">A 57-year-old woman, with a stage IV lung adenocarcinoma received nivolumab during 8 months until disease progression, was referred for pruritic palmo-plantar erythematous papules. Examination also revealed confluent reticular lesions in the buccal mucosa. She received the last cycle of nivolumab 2 months before the lesions appeared. The diagnosis of lichenoid drug reaction due to anti-PD1 therapy was confirmed by a cutaneous biopsy. Treatment with topical corticosteroids was established resolving the lesions after 2 months of treatment.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Pembrolizumab and nivolumab are anti-PD-1 antibodies approved for the treatment of the advanced stages of a wide variety of tumors. Cutaneous adverse events have been reported in about 8.7–42% of these patients. In this context, lichenoid drug eruptions are showing an incidence of 1.2–11%.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">2</span></a> These 3 cases, presented with a confluent and well-defined honeycomb oral pattern, were indistinguishable from idiopathic oral lichen planus lesions. In contrast with the idiopathic form of the disease, anti-PD-1 oral lichenoid reactions reported in these patients tend to have an abrupt onset and a more limited duration. Treatment of this complication includes topical and systemic corticosteroids.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">1</span></a> Temporally or permanent interruption of anti-PD-1 therapy only appears to be necessary in severe cases.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">3</span></a> Early recognition and appropriate management becomes increasingly important as the number of patients on these treatments continues growing.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 598 "Ancho" => 900 "Tamanyo" => 77707 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Reticular streaks converging in a well-defined honeycomb pattern in buccal mucosa in a patient treated with pembrolizumab for metastatic cutaneous melanoma.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib0020" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral manifestations in melanoma patients treated with target or immunomodulatory therapies" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Dika" 1 => "M. Lambertini" 2 => "B. Gouveia" 3 => "M. Mussi" 4 => "E. Marcelli" 5 => "E. Campione" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "J Clin Med" "fecha" => "2021" "volumen" => "101" "paginaInicial" => "1283" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0025" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lichen planus-like drug eruption on anti-PD-1 therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D. Kratzsch" 1 => "J.C. Simon" 2 => "M. Ziemer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ddg.13370" "Revista" => array:6 [ "tituloSerie" => "J Dtsch Dermatol Ges" "fecha" => "2017" "volumen" => "15" "paginaInicial" => "1238" "paginaFinal" => "1240" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29211335" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0030" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cutaneous adverse reactions to anti-PD-1 treatment – a systematic review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A.B. Simonsen" 1 => "J. Kaae" 2 => "E. Ellebaek" 3 => "I.M. Svane" 4 => "C. Zachariae" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2020.04.058" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2020" "volumen" => "83" "paginaInicial" => "1415" "paginaFinal" => "1424" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32320766" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00257753/0000015800000009/v1_202205040537/S0025775321005303/v1_202205040537/en/main.assets" "Apartado" => array:4 [ "identificador" => "66430" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas al Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00257753/0000015800000009/v1_202205040537/S0025775321005303/v1_202205040537/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775321005303?idApp=UINPBA00004N" ]
